Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 50
Filter
1.
J Infect Chemother ; 2024 Jun 19.
Article in English | MEDLINE | ID: mdl-38906374

ABSTRACT

A 21-year-old previously healthy Japanese woman visited an outpatient clinic because of abdominal pain, watery diarrhea, vomiting, and mild fever that had started on the previous day. She traveled to rural and urban areas of Rwanda and returned to Japan 3 days before. Stool culture yielded the Plesiomonas shigelloides strain TMCH301018, against which minimum inhibitory concentrations of cefotaxime and cefotaxime-clavulanate were 128 and ≤0.12/4 µg/mL, respectively. The strain had the blaCTX-M-27 gene and an IncA/C replicon-type plasmid. Moreover, a transformant produced by introduction of an IncA/C plasmid extracted from TMCH301018 into Escherichia coli DH5α was positive for the blaCTX-M-27 gene and fulfilled the criteria of extended-spectrum ß-lactamase (ESBL) production described by the Clinical and Laboratory Standards Institute, indicating that TMCH301018 produced ESBL of CTX-M-27 and the ESBL-encoding gene was located on an IncA/C plasmid. Pathogenicity of TMCH301018 for the patient's complaints was uncertain because a molecular assay detected other enteropathogens in the stool specimen and the symptoms improved within 2 days with administration of oral ciprofloxacin, to which TMCH301018 was not susceptible. To our knowledge, this is the first report describing the isolation of ESBL-producing P. shigelloides.

2.
J Microorg Control ; 29(2): 81-89, 2024.
Article in English | MEDLINE | ID: mdl-38880620

ABSTRACT

Although recent propagation of carbapenemase-producing Enterobacterales (CPE) has become a problem worldwide, the picture of CPE infection in Japan has not fully been elucidated. In this study, we examined clinical and microbiological characteristics of invasive CPE infection occurring at 8 hospitals in Minami Ibaraki Area between July 2001 to June 2017. Of 7294 Enterobacterales strains isolated from independent cases of bacteremia and/or meningitis, 10 (0.14%) were CPE (8 Enterobacter cloacae-complex, 1 Escherichia coli, and 1 Edwardsiella tarda), all of which had the blaIMP-1 gene and susceptible to gentamicin and trimethoprim/sulfamethoxazole. These strains were isolated from 7 adult and 2 infant bacteremia (1 infant patient developed CPE bacteremia twice) after 2007. The most common portal of entry was intravenous catheters. All of the adult patients were recovered, while the infant patients eventually died. Genomic analyses showed that the 8 E. cloacae-complex strains were classified into 5 groups, each of which was exclusively detected in specific facilities at intervals of up to 3 years, suggesting persistent colonization in the facilities. This study showed that invasive CPE infection in the area was rare, caused by IMP-1-type CPE having susceptibility to various antibiotics, and nonfatal among adult patients.


Subject(s)
Anti-Bacterial Agents , Bacteremia , Bacterial Proteins , Enterobacteriaceae Infections , Microbial Sensitivity Tests , beta-Lactamases , Humans , Japan/epidemiology , Bacteremia/microbiology , Bacteremia/drug therapy , Bacteremia/epidemiology , Enterobacteriaceae Infections/microbiology , Enterobacteriaceae Infections/epidemiology , Enterobacteriaceae Infections/drug therapy , beta-Lactamases/genetics , beta-Lactamases/metabolism , Male , Female , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Infant , Middle Aged , Adult , Aged , Enterobacter cloacae/genetics , Enterobacter cloacae/drug effects , Enterobacter cloacae/isolation & purification , Gentamicins/pharmacology , Gentamicins/therapeutic use , Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use , Trimethoprim, Sulfamethoxazole Drug Combination/pharmacology , Aged, 80 and over , Carbapenem-Resistant Enterobacteriaceae/genetics , Carbapenem-Resistant Enterobacteriaceae/isolation & purification
3.
Front Microbiol ; 13: 943877, 2022.
Article in English | MEDLINE | ID: mdl-36532428

ABSTRACT

COVID-19 has a wide range of clinical presentations, and the susceptibility to SARS-CoV-2 infection and the mortality rate also vary by region and ethnicity. Here, we found that rs12329760 in the TMPRSS2 gene, a missense variant common in East Asian populations, contributes to protection against SARS-CoV-2 infection. TMPRSS2 is a protease responsible for SARS-CoV-2 entry and syncytium formation. rs12329760 (c.478G>A, p. V160M) was associated with a reduced risk of moderate symptoms. The enzymatic activity of Met160-TMPRSS2 was lower than that of Val160-TMPRSS2, and thus the viral entry and the syncytium formation of SARS-CoV-2 were impaired. Collectively, these results indicate that the genetic variation in TMPRSS2, which is common in East Asians, is one of the molecular determinants of COVID-19 susceptibility.

4.
J Infect Chemother ; 28(8): 1165-1167, 2022 Aug.
Article in English | MEDLINE | ID: mdl-35361535

ABSTRACT

Sneathia sanguinegens is a fastidious, Gram-negative, rod-shape organism rarely isolated from human specimens. In the present report, we describe a case of periprosthetic knee joint infection due to the organism, which occurred in a female patient receiving immunosuppressants for underlying lupus nephritis. The causative organism was isolated from the synovial fluid in the affected knee joint through inoculating the material on chocolate agar and incubation for 15 days under 5% CO2. Moreover, the organism was capable to be subcultured on chocolate agar with incubation for a few days under 5% CO2, demonstrating that this uncommon organism, although generally considered as a strict anaerobe, is culturable in aerobic condition if appropriate media and a sufficient incubation time are given. The patient was treated with intravenous cefepime, an antibiotic highly active to the isolated organism in an in vitro study, in addition to intraarticular debridement and exchanging a polyethylene insert in the affected joint. The antimicrobial therapy with cefepime was given for 19 days and, thereafter, changed with oral levofloxacin. Although the patient showed full recovery after administration of levofloxacin for 100 days, an in vitro study conducted later revealed that levofloxacin was inactive to the isolated organism.


Subject(s)
Arthritis, Infectious , Prosthesis-Related Infections , Agar/therapeutic use , Anti-Bacterial Agents/therapeutic use , Arthritis, Infectious/drug therapy , Carbon Dioxide/therapeutic use , Cefepime , Female , Fusobacteria , Gram-Negative Bacteria , Humans , Knee Joint , Levofloxacin/therapeutic use , Prosthesis-Related Infections/complications , Prosthesis-Related Infections/drug therapy
5.
Pediatr Gastroenterol Hepatol Nutr ; 24(6): 510-517, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34796095

ABSTRACT

PURPOSE: Consensus is lacking regarding the optimal antibiotic treatment for pediatric complicated appendicitis. This study determined the optimal first-line antibiotic treatment for pediatric patients with complicated appendicitis based on peritoneal fluid cultures. METHODS: This retrospective study examined the cases of pediatric patients who underwent appendectomy for complicated appendicitis at our institution between 2013 and 2019. Peritoneal fluid specimens obtained during appendectomy were cultured for the presence of bacteria. RESULTS: Eighty-six pediatric patients were diagnosed with complicated appendicitis. Of them, bacteria were identified in 54 peritoneal fluid samples. The major identified bacteria were Escherichia coli (n=36 [66.7%]), Bacteroides fragilis (n=28 [51.9%]), α-Streptococcus (n=25 [46.3%]), Pseudomonas aeruginosa (n=10 [18.5%]), Enterococcus avium (n=9 [16.7%]), γ-Streptococcus (n=9 [16.7%]), and Klebsiella oxytoca (n=6 [11.1%]). An antibiotic susceptibility analysis showed E. coli was inhibited by sulbactam/ampicillin in 43.8% of cases versus cefmetazole in 100% of cases. Tazobactam/piperacillin and meropenem inhibited the growth of 96.9-100% of the major identified bacteria. E. coli (100% vs. 84.6%) and P. aeruginosa (100% vs. 80.0%) were more susceptible to amikacin than gentamicin. CONCLUSION: Tazobactam/piperacillin or meropenem is a reasonable first-line antibiotic treatment for pediatric complicated appendicitis. In the case of aminoglycoside use, amikacin is recommended.

6.
J Infect Chemother ; 27(8): 1238-1243, 2021 Aug.
Article in English | MEDLINE | ID: mdl-33722464

ABSTRACT

Although a variety of microorganisms have caused infective endocarditis, Nocardia species have rarely been reported as a causative agent of the disease. We describe a case of nocardial endocarditis, occurring to a 22-year-old Japanese woman during long-term corticosteroid therapy for adult-onset Still's disease and diagnosed after the rupture of cerebral mycotic aneurysm. Echocardiography showed that the causative organism, isolated from the blood and identified as Nocardia nova with an analysis of 16S ribosomal RNA sequences, affected the posterior papillary muscle of the left ventricle. Nocardia-like organisms were also detected in the pus around the raptured aneurysm. After treatment with imipenem/cilastatin plus amikacin for 3 months followed by oral trimethoprim/sulfamethoxazole for 1 year, no relapse of nocardiosis occurred during a follow-up for 3 years. To our knowledge, the present case is the first reported endocarditis due to N. nova.


Subject(s)
Endocarditis, Bacterial , Nocardia Infections , Nocardia , Adult , Endocarditis, Bacterial/diagnosis , Endocarditis, Bacterial/drug therapy , Female , Humans , Nocardia/genetics , Nocardia Infections/diagnosis , Nocardia Infections/drug therapy , Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use , Young Adult
7.
J Infect Chemother ; 26(5): 475-482, 2020 May.
Article in English | MEDLINE | ID: mdl-31924521

ABSTRACT

We examined microbiological and clinical characteristics of invasive Acinetobacter infection occurring in four hospitals located in the Minami-Ibaraki Area. Glucose-non-fermentative Gram-negative bacilli isolated from the blood and the cerebrospinal fluid in independent cases between 2001 and 2014 were consecutively collected and those possibly to be Acinetobacter species were re-identified using molecular methods. Of 158 strains identified as Acinetobacter species, 155 were classified into 16 officially designated species, including 42 Acinetobacter pittii and 40 Acinetobacter baumannii. Imipenem non-susceptibility was detected only in 4 strains, none of which demonstrated multidrug resistance. Retrospective analyses of 154 cases for which medical records were fully available showed that the most common cause of infection was primary bloodstream infection (134 cases), of which 128 were related to intravascular catheter use. The mortality on day 28 after the onset was independently associated with cerebrovascular disease, moderate to severe renal disease, the Pitt bacteremia score, and infection other than primary bloodstream infection but not with appropriate empiric antimicrobial therapy. Isolation of A. baumannii was significantly associated with septic shock but not with the 28-day mortality. These findings, obtained in a region where drug-resistant Acinetobacter strains were much less prevailing, indicated that non-baumannii Acinetobacter species were common pathogens, that the most predominant cause of invasive Acinetobacter infection was intravascular catheter-related infection, that virulence of A. baumannii might be higher than those of other species but its association with mortality was unclear, and that administration of broad-spectrum antibiotics targeting Acinetobacter species might be deferrable in a certain situation.


Subject(s)
Acinetobacter Infections/microbiology , Acinetobacter/genetics , Acinetobacter/isolation & purification , Acinetobacter Infections/drug therapy , Acinetobacter Infections/genetics , Acinetobacter Infections/mortality , Acinetobacter baumannii/genetics , Acinetobacter baumannii/isolation & purification , Adolescent , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Bacteremia/drug therapy , Bacteremia/microbiology , Catheter-Related Infections/drug therapy , Catheter-Related Infections/microbiology , Child , Child, Preschool , Drug Resistance, Bacterial , Female , Humans , Imipenem/therapeutic use , Infant , Infant, Newborn , Japan , Male , Meningitis/drug therapy , Meningitis/microbiology , Microbial Sensitivity Tests , Middle Aged , Retrospective Studies , Risk Factors , Shock, Septic/drug therapy , Shock, Septic/microbiology , Young Adult
8.
J Infect Chemother ; 26(4): 389-392, 2020 Apr.
Article in English | MEDLINE | ID: mdl-31837898

ABSTRACT

A 78-year-old Japanese man, undergoing maintenance hemodialysis for 20 years and having received coronary artery bypass grafting two months before, was hospitalized because of fever with subclinical left-sided pleurisy. Achromobacter xylosoxidans strains exhibiting identical genomic patterns on a macrorestriction analysis were isolated from the blood and the pleural effusion obtained on admission. Physical and radiological examinations did not reveal any lesions in either chest wall or lung adjacent to the effusion, indicating that the organism in the effusion had entered the pleural space via the bloodstream. Immunocompromising conditions due to undergoing maintenance hemodialysis and the presence of the antecedently accumulated pleural effusion may have been associated with the development of hematogenous dissemination. The patient fully recovered only with antibiotic therapy. To our knowledge, the present report is the first describing a case of hematogenous pleural infection caused by A. xylosoxidans.


Subject(s)
Gram-Negative Bacterial Infections/microbiology , Pleural Effusion/microbiology , Achromobacter denitrificans/genetics , Achromobacter denitrificans/isolation & purification , Aged , Anti-Bacterial Agents , Gram-Negative Bacterial Infections/drug therapy , Humans , Male , Pleural Effusion/blood , Pleural Effusion/drug therapy , Renal Dialysis/adverse effects , Tomography, X-Ray Computed
9.
Intern Med ; 58(24): 3605, 2019 12 15.
Article in English | MEDLINE | ID: mdl-31391400
10.
Intern Med ; 58(17): 2573-2576, 2019 Sep 01.
Article in English | MEDLINE | ID: mdl-31118372

ABSTRACT

Sphingobacterium species rarely cause human infection. We herein report two cases of cellulitis complicated with bacteremia due to this genus. The patients, both in their 70s and receiving corticosteroid therapy for their underlying diseases, had antecedent skin injuries in their affected limbs. The patients' symptoms improved promptly and completely with the administration of cefazolin, which did not inhibit the growth of isolated organisms at a concentration of 4 µg/mL.


Subject(s)
Bacteremia/microbiology , Cellulitis/microbiology , Gram-Negative Bacterial Infections/diagnosis , Sphingobacterium , Aged , Anti-Bacterial Agents/therapeutic use , Bacteremia/drug therapy , Cefazolin/therapeutic use , Cellulitis/drug therapy , Female , Gram-Negative Bacterial Infections/drug therapy , Humans , Immunocompromised Host , Male
11.
J Infect Chemother ; 25(7): 509-513, 2019 Jul.
Article in English | MEDLINE | ID: mdl-30879978

ABSTRACT

Cefotaxime-non-susceptible Haemophilus influenzae has rarely been isolated from clinical specimens. Although several reports have shown that amino acid (AA) alteration in penicillin-binding protein 3 (PBP3), encoded by the ftsI gene, reduces activity of cefotaxime, precise mechanisms conferring the non-susceptibility have been unclear. We analyzed the ftsI gene of two clinically isolated cefotaxime-non-susceptible H. influenzae strains, 16-11 and 20-07 (minimum inhibitory concentrations [MICs]: 16 and 8 µg/mL, respectively), and found that their deduced AA sequences of PBP3 included two AA substitutions of G555E and Y557H in addition to previously described AA alterations. To clarify whether the two additional substitutions are requisite for cefotaxime non-susceptibility, we produced transformants of Rd KW20 (cefotaxime MIC: ≤0.06 µg/mL) with the ftsI gene of 16-11. Cefotaxime MICs against transformants M1 and M2, of which deduced PBP3s were altered with that of 16-11 entirely and partially (only the N-terminal side up to the AA position 519), were 8 and 0.25 µg/mL, respectively. We also produced M2-555/7 through site-directed mutagenesis inducing additional substitutions of G555E and Y557H into the PBP3 of M2, against which cefotaxime MIC was 8 µg/mL. These findings show that the additional substitutions of G555E and Y557H in PBP3 with previously described alterations cause cefotaxime non-susceptibility. An additional substitution of either G555E or Y557H alone in altered PBP3 reduced cefotaxime activity but the elevation of MICs were within the category of susceptibility. To our knowledge, this is the first study clarifying a genetic factor in the PBP3 causing cefotaxime non-susceptibility among H. influenzae strains.


Subject(s)
Cefotaxime/pharmacology , Cephalosporin Resistance/genetics , Haemophilus Infections/drug therapy , Haemophilus influenzae/genetics , Penicillin-Binding Proteins/genetics , Amino Acid Substitution , Cefotaxime/therapeutic use , Haemophilus Infections/microbiology , Haemophilus influenzae/isolation & purification , Humans , Microbial Sensitivity Tests
14.
J Infect Chemother ; 23(12): 833-836, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28803866

ABSTRACT

Campylobacter fetus is an organism residing primarily in the gastrointestinal tracts of cattle and sheep and transmitting to humans through ingestion of contaminated food products or surface water. The organism has caused various extraintestinal infections but, to date, purulent pericarditis due to the organism has rarely been described. We report a case of purulent pericarditis due to C. fetus subsp. fetus, occurring in a patient having several predisposing conditions, including receiving hemodialysis therapy, recent surgery for cecal cancer, and administration of esomeprazole. The patient mentioned having eaten homemade raw beef liver two weeks before the onset, suggesting that the ingested food product was contaminated with C. fetus and the organism transmitted to the pericardium through the bloodstream although blood culture was negative. The causative organism, recovered from the pericardial effusion, was unidentifiable with commercial systems but determinable with molecular methods at the subspecies level. The patient fully improved with pericardiocentesis and subsequent administration of ciprofloxacin, to which the organism was considered susceptible, for a total of four weeks. This is the first case of C. fetus pericarditis in which a history of ingesting a raw food product was clearly mentioned.


Subject(s)
Campylobacter Infections/microbiology , Campylobacter fetus/isolation & purification , Pericarditis/microbiology , Raw Foods/microbiology , Animals , Anti-Bacterial Agents/administration & dosage , Base Sequence/genetics , Campylobacter Infections/drug therapy , Campylobacter fetus/genetics , Cattle , Ciprofloxacin/administration & dosage , Gastrointestinal Tract/microbiology , Humans , Liver/microbiology , Male , Middle Aged , Pericarditis/drug therapy , Pericardium/microbiology , Sheep
15.
J Infect Chemother ; 23(3): 185-188, 2017 Mar.
Article in English | MEDLINE | ID: mdl-27681234

ABSTRACT

We report a case of thoracic empyema caused by Campylobacter rectus, an organism considered as a periodontal pathogen but rarely recovered from extraoral specimens. The patient fully recovered through drainage of purulent pleural fluid and administration of antibiotics. The present case illustrates that C. rectus can be a cause of not only periodontal disease but also pulmonary infection.


Subject(s)
Campylobacter rectus/isolation & purification , Empyema, Pleural/microbiology , Aged , Anti-Bacterial Agents/therapeutic use , Campylobacter rectus/drug effects , Drainage/methods , Empyema, Pleural/drug therapy , Humans , Male
16.
J Infect Chemother ; 22(1): 61-3, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26492859

ABSTRACT

We examined prevalence of high-level aminoglycoside resistance (HLAR) in Enterococcus faecalis and Enterococcus faecium causing invasive infection in the Minami Ibaraki Area. Ten strains of both species each, recovered from the blood or the cerebrospinal fluid between 2003 and 2014, were randomly selected every year. High-level resistance to gentamicin (HLR-GM) and streptomycin (HLR-SM) was detected in 34% (41 of 120 strains) and 18% (21) of E. faecalis and 9% (11) and 39% (48) of E. faecium, respectively. In comparisons of the proportions among three four-year periods, HLR-SM among E. faecium was significantly lower in the 2011-2014 period. All strains with HLR-GM were positive for the aac(6')-Ie-aph(2″)-Ia gene. The ant(6')-Ia gene was detected in all with HLR-SM except for one E. faecalis strain. The present study showed that prevalence of HLR-GM among E. faecalis and E. faecium causing invasive infection in this area was nearly equivalent to that described in previous studies in Japan and that proportions of strains with HLAR did not vary during the study period except for that of HLR-SM among E. faecium.


Subject(s)
Aminoglycosides , Drug Resistance, Bacterial , Enterococcus faecalis/isolation & purification , Enterococcus faecium/isolation & purification , Gram-Positive Bacterial Infections/microbiology , Aminoglycosides/pharmacology , Aminoglycosides/therapeutic use , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Bacterial Proteins , Gram-Positive Bacterial Infections/drug therapy , Gram-Positive Bacterial Infections/epidemiology , Humans , Japan/epidemiology , Phosphotransferases (Alcohol Group Acceptor)
17.
J Infect Chemother ; 21(12): 849-56, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26433422

ABSTRACT

The Verigene Gram-positive blood culture test (BC-GP) and the Verigene Gram-negative blood culture test (BC-GN) identify representative Gram-positive bacteria, Gram-negative bacteria and their antimicrobial resistance by detecting resistance genes within 3 h. Significant benefits are anticipated due to their rapidity and accuracy, however, their clinical utility is unproven in clinical studies. We performed a clinical trial between July 2014 and December 2014 for hospitalized bacteremia patients. During the intervention period (N = 88), Verigene BC-GP and BC-GN was used along with conventional microbiological diagnostic methods, while comparing the clinical data and outcomes with those during the control period (N = 147) (UMIN registration ID: UMIN000014399). The median duration between the initiation of blood culture incubation and the reporting time of the Verigene system results was 21.7 h (IQR 18.2-26.8) and the results were found in 88% of the cases by the next day after blood cultures were obtained without discordance. The hospital-onset infection rate was higher in the control period (24% vs. 44%, p = 0.002), however, no differences were seen in co-morbidities and severity between the control and intervention periods. During the intervention period, the time of appropriate antimicrobial agents' initiation was significantly earlier than that in the control period (p = 0.001) and most cases (90%; 79/88) were treated with antimicrobial agents with in-vitro susceptibility for causative bacteria the day after the blood culture was obtained. The costs for antimicrobial agents were lower in the intervention period (3618 yen vs. 8505 yen, p = 0.001). The 30-day mortality was lower in the intervention period (3% vs. 13%, p = 0.019).


Subject(s)
Bacteremia/diagnosis , Bacteremia/microbiology , Molecular Diagnostic Techniques/instrumentation , Aged , Anti-Bacterial Agents/therapeutic use , Bacteremia/drug therapy , Communicable Diseases/diagnosis , Communicable Diseases/drug therapy , Communicable Diseases/microbiology , Cross Infection/diagnosis , Cross Infection/drug therapy , Cross Infection/microbiology , Female , Gram-Negative Bacteria/drug effects , Gram-Negative Bacteria/genetics , Gram-Positive Bacteria/drug effects , Gram-Positive Bacteria/genetics , Humans , Male , Microarray Analysis/methods , Prospective Studies
18.
Intern Med ; 54(7): 853-6, 2015.
Article in English | MEDLINE | ID: mdl-25832956

ABSTRACT

Neisseria elongata, a normal resident in the human oral cavity, rarely causes invasive infections. We herein report a case of endocarditis caused by Neisseria elongata subsp. nitroreducens that occurred in a patient without any apparent cardiac complications. The patient received aortic valve replacement following the administration of intravenous beta-lactam for five weeks. To our knowledge, this is the first published case in Japan of N. elongata infection in a patient without a prosthetic device.


Subject(s)
Aortic Valve Insufficiency/microbiology , Endocarditis, Bacterial/microbiology , Neisseria elongata , Neisseriaceae Infections , Aged , Aortic Valve , Aortic Valve Insufficiency/surgery , Endocarditis, Bacterial/surgery , Heart Valve Prosthesis , Heart Valve Prosthesis Implantation , Humans , Male
19.
J Infect Chemother ; 21(5): 395-7, 2015 May.
Article in English | MEDLINE | ID: mdl-25737074

ABSTRACT

Salmonella enterica subsp. enterica serovar Choleraesuis, an organism highly adapted to swine, rarely causes invasive human infection. We describe a fatal case of Salmonella ser. Choleraesuis infection developing iliopsoas abscess. A part of organisms recovered from the blood formed mucoid colonies, which became reactive to anti-O antigen antisera after either heat treatment or subculture through semisolid agar.


Subject(s)
Mucus/metabolism , Psoas Abscess/microbiology , Salmonella enterica/metabolism , Aged , Fatal Outcome , Humans , Male , O Antigens/analysis , Salmonella enterica/immunology , Serotyping
20.
J Infect Chemother ; 21(1): 62-4, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25127155

ABSTRACT

A 37-year-old, human immunodeficiency virus-1-infected Japanese man was referred because of nephrotic syndrome following emergence of generalized skin rash. Serological tests for syphilis turned out to be positive within ten months of the referral. Abdominal echography incidentally revealed a solitary intrahepatic mass without a detectable blood flow in segment 7. The patient's signs and symptoms, as well as the intrahepatic mass, resolved promptly after administration of amoxicillin. We consider that, in the present case, secondary syphilis caused the nephrotic syndrome and the intrahepatic mass, both of which have rarely been reported to date.


Subject(s)
HIV Infections , Liver Neoplasms , Nephrotic Syndrome , Syphilis , Adult , HIV-1 , Humans , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...